197 related articles for article (PubMed ID: 24200760)
1. Efficacy and safety of ranolazine in patients with chronic stable angina.
Kloner RA; Hines ME; Geunes-Boyer S
Postgrad Med; 2013 Nov; 125(6):43-52. PubMed ID: 24200760
[TBL] [Abstract][Full Text] [Related]
2. Ranolazine: a review of its use as add-on therapy in patients with chronic stable angina pectoris.
Keating GM
Drugs; 2013 Jan; 73(1):55-73. PubMed ID: 23329466
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).
Kosiborod M; Arnold SV; Spertus JA; McGuire DK; Li Y; Yue P; Ben-Yehuda O; Katz A; Jones PG; Olmsted A; Belardinelli L; Chaitman BR
J Am Coll Cardiol; 2013 May; 61(20):2038-45. PubMed ID: 23500237
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with ranolazine in a veteran population with chronic stable angina.
Reeder DN; Gillette MA; Franck AJ; Frohnapple DJ
Ann Pharmacother; 2012 Jan; 46(1):42-50. PubMed ID: 22215689
[TBL] [Abstract][Full Text] [Related]
5. Ranolazine: effects on ischemic heart.
Rognoni A; Barbieri L; Cavallino C; Bacchini S; Veia A; Degiovanni A; Rametta F; Nardi F; Lazzero M; Lupi A; Bongo AS
Recent Pat Cardiovasc Drug Discov; 2013 Dec; 8(3):197-203. PubMed ID: 23961914
[TBL] [Abstract][Full Text] [Related]
6. Advances in the management of stable angina.
Trujillo TC
J Manag Care Pharm; 2006 Oct; 12(8 Suppl):S10-6. PubMed ID: 23577423
[TBL] [Abstract][Full Text] [Related]
7. Use of ranolazine in patients with stable angina pectoris.
Khera S; Kolte D; Aronow WS
Cardiology; 2014; 128(3):251-8. PubMed ID: 24852049
[TBL] [Abstract][Full Text] [Related]
8. Ranolazine for the management of coronary artery disease.
Cheng JW
Clin Ther; 2006 Dec; 28(12):1996-2007. PubMed ID: 17296457
[TBL] [Abstract][Full Text] [Related]
9. Ranolazine in the management of chronic stable angina.
Zerumsky K; McBride BF
Am J Health Syst Pharm; 2006 Dec; 63(23):2331-8. PubMed ID: 17106005
[TBL] [Abstract][Full Text] [Related]
10. Ranolazine (Ranexa) for chronic stable angina.
Ndegwa S
Issues Emerg Health Technol; 2007 Jun; (99):1-6. PubMed ID: 17595750
[TBL] [Abstract][Full Text] [Related]
11. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
Melloni C; Newby LK
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
[TBL] [Abstract][Full Text] [Related]
12. Ranolazine for the treatment of refractory angina in a veterans population.
Greene RS; Rangel RM; Edwards KL; Chastain LM; Brouse SD; Alvarez CA; Collins LJ; Brilakis ES; Banerjee S
Cardiovasc Revasc Med; 2012; 13(2):141.e1-5. PubMed ID: 21856249
[TBL] [Abstract][Full Text] [Related]
13. Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial.
Sendón JL; Lee S; Cheng ML; Ben-Yehuda O;
Eur J Prev Cardiol; 2012 Oct; 19(5):952-9. PubMed ID: 22689417
[TBL] [Abstract][Full Text] [Related]
14. Ranolazine: new drug. Stable angina: not worth the risk.
Prescrire Int; 2009 Aug; 18(102):148-7. PubMed ID: 19743543
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.
Chaitman BR
J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S47-64. PubMed ID: 15378131
[TBL] [Abstract][Full Text] [Related]
16. [Ranolazine--new treatment of chronic stable angina pectoris].
Ahlehoff O; Hansen PR
Ugeskr Laeger; 2009 Dec; 171(50):3705-7. PubMed ID: 20003868
[TBL] [Abstract][Full Text] [Related]
17. Update on ranolazine in the management of angina.
Codolosa JN; Acharjee S; Figueredo VM
Vasc Health Risk Manag; 2014; 10():353-62. PubMed ID: 25028555
[TBL] [Abstract][Full Text] [Related]
18. Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE).
Koren MJ; Crager MR; Sweeney M
J Am Coll Cardiol; 2007 Mar; 49(10):1027-34. PubMed ID: 17349881
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c.
Arnold SV; McGuire DK; Spertus JA; Li Y; Yue P; Ben-Yehuda O; Belardinelli L; Jones PG; Olmsted A; Chaitman BR; Kosiborod M
Am Heart J; 2014 Oct; 168(4):457-465.e2. PubMed ID: 25262254
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials.
Banon D; Filion KB; Budlovsky T; Franck C; Eisenberg MJ
Am J Cardiol; 2014 Mar; 113(6):1075-82. PubMed ID: 24462341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
